Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, S.Y. | - |
dc.contributor.author | Cho, W. | - |
dc.contributor.author | Abd, El-Aty A.M. | - |
dc.contributor.author | Hacimuftuoglu, A. | - |
dc.contributor.author | Jeong, J.H. | - |
dc.contributor.author | Jung, T.W. | - |
dc.date.accessioned | 2023-03-08T07:23:11Z | - |
dc.date.available | 2023-03-08T07:23:11Z | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 0006-2952 | - |
dc.identifier.issn | 1873-2968 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/61397 | - |
dc.description.abstract | Valdecoxib (VAL) is one of the non-steroidal anti-inflammatory drugs (NSAIDs) used to treat inflammatory disorders, such as rheumatoid arthritis, osteoarthritis, and menstrual cramps. Recently, VAL ameliorates skeletal muscle insulin resistance via suppression of inflammation. However, the effects of VAL on lipid metabolism in hepatocytes have not been seen yet. This study investigated the effects of VAL on lipid accumulation and lipogenesis in human primary hepatocytes. Treatment with VAL suppressed lipid accumulation and expressions of lipogenic genes, such as processed sterol regulatory element binding proteins (SREBP1) and stearoyl-CoA desaturase-1 (SCD1) in palmitate-treated hepatocytes. Furthermore, VAL ameliorated dose-dependently palmitate-induced ER stress markers. Treatment of hepatocytes with VAL increased AMPK phosphorylation and SIRT6 expression. siRNA-mediated suppression of AMPK or SIRT6 abolished the effects of VAL on lipid accumulation, lipogenesis, and endoplasmic reticulum (ER) stress in palmitate-treated hepatocytes. Administration of VAL ameliorated hepatic lipid accumulation and lipogenic protein expression in HFD-fed mice. Moreover, in vivo AMPK siRNA transfection abolished the effects of VAL on hepatic steatosis and lipid metabolism. These results suggest that VAL suppresses ER stress through the AMPK/SIRT6 pathway, thereby attenuating hepatic steatosis under hyperlipidemic conditions. Using VAL, the current study results provide clues for developing a novel therapeutic agent for treating non-alcoholic fatty liver disease. © 2022 Elsevier Inc. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier Inc. | - |
dc.title | Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bcp.2022.115022 | - |
dc.identifier.bibliographicCitation | Biochemical Pharmacology, v.199 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000792237300003 | - |
dc.identifier.scopusid | 2-s2.0-85127228320 | - |
dc.citation.title | Biochemical Pharmacology | - |
dc.citation.volume | 199 | - |
dc.type.docType | Article; Early Access | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | AMPK | - |
dc.subject.keywordAuthor | Autophagy | - |
dc.subject.keywordAuthor | ER stress | - |
dc.subject.keywordAuthor | NAFLD | - |
dc.subject.keywordAuthor | SIRT6 | - |
dc.subject.keywordAuthor | Valdecoxib | - |
dc.subject.keywordPlus | FATTY LIVER-DISEASE | - |
dc.subject.keywordPlus | UNFOLDED PROTEIN RESPONSE | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | SIRT6 | - |
dc.subject.keywordPlus | AMPK | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | ACCUMULATION | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.